## SLAB: Silicon Laboratories, Inc. - XLK: Technology

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 3.0% in lower entry zone (3.0-6.0%), top quartile (88th pct) cross-sectional ranking. Short-term MRS_5 (1.5%) confirms momentum alignment. Strong momentum (+2.0% 5-day acceleration). Outperforming sector by 3.6%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($120.67)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 3 ($0.02M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 59.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- FMR, LLC: 15.0% (+0.8%)
- Blackrock Inc.: 13.7% (+2.5%)
- Vanguard Group Inc: 11.8% (+1.9%)
- State Street Corpora: 4.7% (+2.4%)
- Macquarie Group Limi: 3.0% (-8.6%)

### Key Risks

1. Valuation stretched: PEG 3.0x requires aggressive growth execution.
2. Elevated short interest (8.8%): bears positioning against stock.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- Momentum building: MRS_10 improving +2.0% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.03 signals overvaluation risk, limited margin of safety. Forward P/E 48.1x attractive for 197% earnings growth. Balance sheet: strong liquidity (4.5x), low leverage (D/E 0.17). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $4.8B |
| Beta | 1.56 |
| 52W Range | $82.82 - $160.00 |
| Short Interest | 8.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.03 |
| Forward P/E | 48.1 |
| Current P/E | 142.8 |
| YoY Growth | 197.1% |
| EPS Direction | RISING |

### Technicals

MRS_10 strengthening from 1.0% to 3.0% (+2.0% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 88th percentile. MRS_5 at 1.5% confirms short-term momentum alignment. Outperforming sector by 3.6pp, stock-specific strength. MACD histogram positive (1.17), confirming momentum. RSI neutral at 56.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.03% (CS: 89) | Strong |
| RSI_14 | 55.5 | Neutral |
| MACD Histogram | 1.17 | Bullish |
| vs SMA20 | 1.040x | Above |
| vs SMA50 | 1.000x | Below |
| vs SMA200 | 1.006x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $129.39
- **Stop Loss:** $120.67 (6.7% risk)
- **Target:** $142.47 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 137
- **Position Value:** $17,726.43
- **Portfolio %:** 17.73%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-02-03 (Est: $0.55)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.31 | $0.32 | +4.2% |
| 2025Q2 | $0.09 | $0.11 | +18.7% |
| 2025Q1 | $-0.09 | $-0.08 | +10.9% |
| 2024Q4 | $-0.11 | $-0.11 | -1.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*